β2-adrenergic receptor genotype and survival after acute coronary syndrome [3]

JAMA

Volumn 295, Issue 7, 2006, Pages 756-757

  Snyder, Eric M ^a   Johnson, Bruce D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR;

ACUTE CORONARY SYNDROME; BETA ADRENERGIC RECEPTOR BLOCKING; CHRONOTROPISM; COMPARATIVE STUDY; GENOTYPE; HUMAN; INCIDENCE; INOTROPISM; LETTER; MORTALITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; GENETIC POLYMORPHISM; GENETICS; HEART INFARCTION; NOTE; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; ANGINA, UNSTABLE; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 32644448108     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.7.756     Document Type: Letter

References (5)

1. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. β2-Adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome. JAMA. 2005;294:1526-1533.
2. Tang W, Devereux RB, Kitzman DW, et al. The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. Am J Hypertens. 2003;16:945-951.
3. Brodde OE. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 1991;43:203-242.
4. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A. 2001;98:1607-1612.
5. Bosch X, Theroux P. Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2005;150:215-220.